Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Smith, , Timothy,
DOB: 10-SEP-1941 (Age: 84)
Gender: male
Address:
9 Jeffrey orchard
NW1 North Joshuaville (United Kingdom)
ID: 8029-862360-6 (ECI)
Report
Date: 20-JAN-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 20-JAN-2025

Chemistry

Test 20-JAN-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 184.1 H 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 12.0 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.4 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.1 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.7 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.8 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 247.3 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 326.1 H 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 156.0 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 26.1 L 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 5.1 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significant hyperglycemia with normal HbA1c, suggesting possible acute glucose elevation. Lipid profile is markedly abnormal with high total cholesterol, high LDL, high triglycerides, and low HDL, indicating increased cardiovascular risk. Renal function and electrolytes are within normal limits, and there is no evidence of microalbuminuria. Recommend further evaluation and management of dyslipidemia and hyperglycemia.